• Professor of Medicine, Harvard Medical School
• Vice Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham & Women’s Hospital

Dr. Schneeweiss’ research is funded by multiple NIH, PCORI, and FDA grants and focuses on the comparative effectiveness and safety of biologics and pharmaceuticals. He has developed analytic methods to improve the validity of epidemiologic studies using complex healthcare databases particularly for newly marketed medical products. Bundling such improved methods into a rapid-cycle analytics framework is the overarching theme of his research.

He is Director of the Harvard-Brigham Drug Safety Research Center funded by FDA/CDER and Methods Lead of the FDA Sentinel program

Sc.D., 2000, Harvard School of Public Health
S.M., 1994, Harvard School of Public Health
M.D., 1992, Ludwig-Maximilians-University, Munich

F.A.C.E., F.I.S.P.E., F.C.P.